Myriad Genetics MYGN Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's common stock, shares authorized (in shares)?
- Myriad Genetics (MYGN) reported common stock, shares authorized (in shares) of $150M in Q1 2026.
- How has Myriad Genetics's common stock, shares authorized (in shares) changed year-over-year?
- Myriad Genetics's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $150M to $150M.